QPharma launches Neolytica for AI-focused analytics

By The Science Advisory Board staff writers

QPharma has launched Neolytica, a new subsidiary focused on artificial intelligence (AI) for healthcare analytics.

QPharma's move to invest in data analytics and AI meshes well with the company's expertise in the pharmaceutical industry, in particular key opinion leader (KOL) mapping and healthcare professional (HCP) targeting. Neolytica's analytical solutions will use next-generation technologies like natural language processing, AI, face recognition, and chatbots.

Neolytica will focus its efforts on the use of AI in medical affairs, market access, commercial marketing, and commercial sales, according to the company.


Copyright © 2021 scienceboard.net
 

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a Scienceboard.net password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?